Rituximab-resistant chimeric antigen receptors and uses thereof
PH12021552415B1Active Publication Date: 2026-11-06ALLOGENE THERAPEUTICS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12021552415
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-09-28
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2041-09-28
Abstract
Provided herein are polynucleotides encoding chimeric antigen receptors (CARs) comprising a CD19 antigen binding domain that specifically binds to CD19 and is resistant to rituximab binding; and immune cells comprising these CD19-specific CARs, e.g., CAR-T cells. Also provided are methods of making and using these CD19-specific CARs, and immune cells comprising these CD19-specific CARs.
Need to check novelty before this filing date? Find Prior Art
